Ocular involvement in patient with Wegener's granulomatosis - A case report;Przebieg ziarniniaka Wegenera z zajȩciem gałki ocznej - Opis przypadku

Polskie Archiwum Medycyny Wewnetrznej

Volumn 115, Issue 3, 2006, Pages 243-247

  Majewski, Dominik ^a   Puszczewicz, Mariusz ^a   Zimmermann Górska, Irena ^a   Kołczewska, Aleksandra ^a   Tuchocka Piotrowska, Aleksandra ^a  

^a Katedra i Klinika Reumatologiczno Rehabilitacyjna i Chorób Wewnetrznych AM im K Marcinkowskiego   (Poland)

Author keywords

ANCA; Ocular complications; Vasculitis; Wegener's granulomatosis

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; EYE DISEASE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; SYMPTOMATOLOGY; VASCULITIS; WEGENER GRANULOMATOSIS; MIDDLE AGED; TREATMENT OUTCOME;

EYE DISEASES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; TREATMENT OUTCOME; WEGENER GRANULOMATOSIS;

EID: 33746513187     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Brockmann H., Schwarting A., Kriegsmann J. i wsp. Proteinase-3 as the major autoantigen of c-ANCA is strongly expressed in lung tissue of patients with Wegeners granulomatosis. Arthritis Res. 2002; 4: 220.
2. Brouwer E., Huitema M.G., Mulder A.H. i wsp. Neutrophil activation in vitro and in vivo in Wegener's granulomatosis. Kidney Int. 1994; 45: 1120.
3. Di Comite G., Bonavida G., Bozzolo E. i wsp. Wegeners granulomatosis: an analysis of 50 patients. Reumatismo. 2005; 57: 187.
4. Krzystolik Z., Fiedorowicz-Fabrycy I., Karczewicz D. Ocular symptoms in Wegener's granulomatosis - personal observations. Klin Oczna. 1993; 95: 183.
5. Życińska K., Wardyn K., Chipczyńska B. Zajȩcie gałki ocznej. [w:] Wardyn K., Życińska K., (red.): Pierwotne układowe zapalenia naczyń. Wrocław: Wydawnictwo Medyczne Urban & Partner; 2004. s.71.
6. Conn D.L., Hunder G.G. Necrotizing vasculitis. [w:] Kelly W.N., Harris E.D., Ruddy S. (eds.): Textbook of Rheumatology, ed. 2. Philadelphia: WB Saunders; 1985. s.1137.
7. Malyak M. Wegener's granulomatosis and other ANCA-associated diseases, [w:] West S. (ed.): Rheumatology secrets, ed. 2. Philadelphia: Hanley & Belfus, Inc.; 2002. s.222.
8. Harper S.L., Letko E., Samson C.M. i wsp. Wegener's granulomatosis: the relationship between ocular and systemic disease. J Rheumatol. 2001; 28: 1025.
9. Cuende E., Mena A.R., Andonegui J., Minguela I., Vesga J.C. Ocular involvement in Wegener's granulomatosis responding to intravenous cyclophosphamide. Rheumatology, (Oxford); 2001: 40, 1066.
10. Blum M., Andrassy K., Adler D., Hartmann M., Volcker H.E. Early experience with intravenous immunoglobulin treatment in Wegener's granulomatosis with ocular involvement. Graefes Arch Clin Exp Ophthalmol. 1997; 235: 599.
11. El-Shabrawi Y., Mangge H., Hermann J. Anti-tumor necrosis factor alpha treatment in chronic recurrent inflammation of the anterior segment of the eye in patients resistant to standard immunomodulatory treatment. Ann Rheum Dis. 2003; 62: 1243.
12. Talar-Williams C., Sneller M.C., Langford C.A., Smith J.A., Cox T.A., Robinson M.R. Orbital socket contracture: a complication of inflammatory orbital disease in patients with Wegener's granulomatosis. Br J Ophthalmol. 2005; 89: 493.